BroadOak Capital Partners

BroadOak Capital Partners is a life sciences-focused venture capital firm that provides direct investments and advisory services to companies in the life sciences tools, diagnostics, and biopharma services sectors. Since its inception in 2006, the firm has invested in over 75 companies and advised on more than 50 successful mergers and acquisitions. BroadOak's team leverages deep industry expertise and a flexible investment approach to support the growth and success of its portfolio companies.

The firm's investment strategy focuses on commercial-stage companies with proven market needs for their products or services. BroadOak's in-house expertise, access to proprietary information, and reputation built on over 15 years of experience enable it to deliver results that exceed expectations. The firm has invested in more than 75 companies and advised on over 50 successful mergers and acquisitions.

BroadOak's commitment to the life sciences sector is further demonstrated by its recent addition of over $200 million of permanent capital to its investment platform, allowing it to deploy patient, flexible capital across market cycles without the constraints of traditional fund structures and time horizons. This capital base enables BroadOak to pursue its life sciences growth capital strategy over a longer horizon and to be opportunistic in special situations.